News
Telerehabilitation may be effective in MS
Patients with MS may achieve equivalent benefits and increased cost savings with telerehabilitation, compared with outpatient rehabilitation.
News
Nilotinib is safe in moderate and advanced Parkinson’s disease
Although the drug is safe and tolerable, it penetrates the brain poorly and does not change levels of dopamine or its metabolites.
News
Chronic migraine is associated with changes in the amygdala
Changes in the volume and connectivity of the amygdala are associated with headache frequency and affective states.
News
AAN publishes ethical guidance on patient care during the pandemic
The guidance reviews adaptations to inpatient and outpatient care and indicates the need for protocols to allocate scarce medical resources.
News
New research confirms the efficacy and safety of onasemnogene abeparvovec for SMA
Three investigations indicate that the treatment allows children, including those who are presymptomatic, to achieve and maintain motor milestones...
News
Researchers identify a cause of L-DOPA–induced dyskinesia in Parkinson’s disease
The identification of a protein that contributes to abnormal involuntary movements may enable the development of improved treatments for Parkinson...
News
Economic burden of migraine increases with the number of treatment failures
Total medical visit costs and total prescription costs are highest among patients with three or more treatment failures.
News
Prior head injury is associated with severe Parkinson’s disease phenotype
Head injury before diagnosis was associated with greater motor and nonmotor symptom burden in an analysis of two patient cohorts.
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
News
How do neurologists choose an acute treatment for migraine?
STOWE, VT. – The route of administration, the medicine’s tolerability, and the patient’s preferences all must be considered to enable effective...
News
Database will collect data on COVID-19 in patients with MS
A registry is gathering information on patients throughout the United States with a view to understanding outcomes and improving treatment.
News
American Lung Association announces $25 million initiative to end COVID-19
The initiative will fund research, improve public health measures, and promote preparedness for future respiratory virus pandemics.
News
Amid coronavirus concerns, researchers urge mental health interventions for patients with dementia
The response of dementia experts and mental health professionals in China to the COVID-19 pandemic could inform interventions worldwide for...
News
When is preventive treatment of migraine appropriate?
STOWE, VT. – Preventive treatment of migraine can reduce disability and decrease the risk of transformation to...